Literature DB >> 16850303

Intramuscular diffuse-type giant cell tumor within the hamstring muscle.

Tatsuya Yoshida1, Akio Sakamoto, Kazuhiro Tanaka, Yukihide Iwamoto, Yoshinao Oda, Teiyu Izumi, Masazumi Tsuneyoshi.   

Abstract

Diffuse-type giant cell tumor (D-TGCT) is known as a synonym for pigmented villonodular synovitis (PVS), a condition usually found in the large joints. We report an extremely rare case of D-TGCT which was located within the hamstring muscle. The lesion was an incidental finding in a 62-year-old man who underwent positron emission tomography (PET) as part of a staging evaluation for gastric cancer. The lesion was resected. There has been neither metastasis nor recurrence during the 6-month period since resection. This case demonstrates that PVS/D-TGCT may have a high SUV on PET imaging, and for this reason PET may be useful for detecting both the tumor and any recurrence.

Entities:  

Mesh:

Year:  2006        PMID: 16850303     DOI: 10.1007/s00256-006-0170-9

Source DB:  PubMed          Journal:  Skeletal Radiol        ISSN: 0364-2348            Impact factor:   2.199


  9 in total

1.  Magnetic resonance imaging of localized giant cell tumour of the tendon sheath (MRI of localized GCTTS).

Authors:  L De Beuckeleer; A De Schepper; F De Belder; J Van Goethem; M C Marques; J Broeckx; K Verstraete; F Vermaut
Journal:  Eur Radiol       Date:  1997       Impact factor: 5.315

Review 2.  FDG uptake, tumour characteristics and response to therapy: a review.

Authors:  T A Smith
Journal:  Nucl Med Commun       Date:  1998-02       Impact factor: 1.690

3.  Diffuse-type giant cell tumor: clinicopathologic and immunohistochemical analysis of 50 cases with extraarticular disease.

Authors:  N S Somerhausen; C D Fletcher
Journal:  Am J Surg Pathol       Date:  2000-04       Impact factor: 6.394

4.  11C-choline PET for the detection of bone and soft tissue tumours in comparison with FDG PET.

Authors:  H Zhang; M Tian; N Oriuchi; T Higuchi; H Watanabe; J Aoki; S Tanada; K Endo
Journal:  Nucl Med Commun       Date:  2003-03       Impact factor: 1.690

5.  Evaluation of breast masses and axillary lymph nodes with [F-18] 2-deoxy-2-fluoro-D-glucose PET.

Authors:  L P Adler; J P Crowe; N K al-Kaisi; J L Sunshine
Journal:  Radiology       Date:  1993-06       Impact factor: 11.105

6.  Incidental detection of pigmented villonodular synovitis on FDG PET.

Authors:  Mehmet T Kitapci; R Edward Coleman
Journal:  Clin Nucl Med       Date:  2003-08       Impact factor: 7.794

7.  Probability of malignancy in solitary pulmonary nodules using fluorine-18-FDG and PET.

Authors:  N C Gupta; J Maloof; E Gunel
Journal:  J Nucl Med       Date:  1996-06       Impact factor: 10.057

8.  Comparison of 11C-choline PET and FDG PET for the differential diagnosis of malignant tumors.

Authors:  Mei Tian; Hong Zhang; Noboru Oriuchi; Tetsuya Higuchi; Keigo Endo
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-03-11       Impact factor: 9.236

9.  Head and neck cancer: detection of recurrence with PET and 2-[F-18]fluoro-2-deoxy-D-glucose.

Authors:  M Lapela; R Grénman; T Kurki; H Joensuu; S Leskinen; P Lindholm; M Haaparanta; U Ruotsalainen; H Minn
Journal:  Radiology       Date:  1995-10       Impact factor: 11.105

  9 in total
  2 in total

1.  Nonsurgical giant cell tumour of the tendon sheath or of the diffuse type: are MRI or 18F-FDG PET/CT able to provide an accurate prediction of long-term outcome?

Authors:  Laurent Dercle; Roland Chisin; Samy Ammari; Quentin Gillebert; Monia Ouali; Cyril Jaudet; Jean-Pierre Delord; Lawrence Dierickx; Slimane Zerdoud; Martin Schlumberger; Frédéric Courbon
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-11-01       Impact factor: 9.236

2.  Incidental findings in the skeletal musculature on computed tomography.

Authors:  Dominik Schramm; Annkathrin Justus; Andreas G Bach; Alexey Surov
Journal:  Br J Radiol       Date:  2016-12-12       Impact factor: 3.039

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.